Skip to main content

Kushal Kumar Rana

IOL Chemicals and Pharmaceuticals Limited

Equibles does not estimate personal net worth.

About Kushal Kumar Rana

Kushal Kumar Rana has spoken on 3 earnings calls across 1 company, most recently for IOL Chemicals and Pharmaceuticals Limited on November 2, 2026. IOL Chemicals and Pharmaceuticals Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Kushal Kumar Rana on recent calls

“So, currently, our plans are to convert our existing molecules either into the bulk tablets or into the customized requirement, be it blister packing or something.”
Other, Earnings Call for the Quarter Ended September 30, 2026 ·
“Due to war, the prices were increased substantially in the month of March itself, but after that, it is stable to some extent, and now the prices are, you can say, not on the overturn from the last one month.”
Other, Earnings Call for the Quarter Ended June 30, 2026 ·
“The product which you have just mentioned, just as you have named, all our existing products, including ibu, metformin, clopidogrel, and this pano-favorite, they are running almost at 85 to 95 percent capacity utilization.”
Other, Earnings Call for the Quarter Ended March 31, 2026 ·

Affiliation history

  • IOL Chemicals and Pharmaceuticals Limited

    Transcript header (unverified)

    Current

Company network

IOL Chemicals and Pharmaceuticals Limited

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

3 appearances Latest appearance 2026-11-02

Recent activity

  • Earnings call

    Earnings Call for the Quarter Ended September 30, 2026

    IOL Chemicals and Pharmaceuticals Limited

  • Earnings call

    Earnings Call for the Quarter Ended June 30, 2026

    IOL Chemicals and Pharmaceuticals Limited

  • Earnings call

    Earnings Call for the Quarter Ended March 31, 2026

    IOL Chemicals and Pharmaceuticals Limited